• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄糖对CHO细胞的可利用性会影响单克隆抗体的细胞内脂质连接寡糖分布、位点占据情况以及N-糖基化谱。

The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and the N-glycosylation profile of a monoclonal antibody.

作者信息

Liu Bo, Spearman Maureen, Doering John, Lattová Erica, Perreault Hélène, Butler Michael

机构信息

Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada R3T 2N2.

Department of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada R3T 2N2.

出版信息

J Biotechnol. 2014 Jan 20;170:17-27. doi: 10.1016/j.jbiotec.2013.11.007. Epub 2013 Nov 25.

DOI:10.1016/j.jbiotec.2013.11.007
PMID:24286971
Abstract

The glycosylation pattern of a chimeric heavy chain antibody (EG2) produced from CHO cells was affected by the glucose concentration (0-25mM) of cultures established at high density (>10(6)ml(-1)) over 24h. The resulting proportion of non-glycosylated Mab was directly correlated to the exposure time of cells to media depleted of glucose. Deprivation of glucose for the full 24h resulted in a 45% non-glycosylated Mab fraction. Analysis of steady state levels of intracellular lipid-linked oligosaccharides (LLOs) showed that under glucose limitation there was a reduction in the amount of full length LLO (Glc3Man9GlcNac2), with a concomitant increase in the smaller mannosyl-glycans (Man2-5GlcNAc2). Glycan microheterogeneity was quantified by galactosylation and sialylation indices (GI and SI) which showed a direct correlation to the cell specific glucose uptake. The GI increased to 0.83 following media supplementation with a cocktail of uridine, manganese and galactose. This is significantly higher than for a fully humanized antibody (DP12) produced under the similar conditions or for similar antibodies reported in the literature. The high GI of the chimeric antibody (EG2) may be due to its low molecular weight and unusual structure. These findings are important in relation to the low substrate that may occur in fed-batch cultures for Mab production.

摘要

由CHO细胞产生的嵌合重链抗体(EG2)的糖基化模式受到在高密度(>10⁶ml⁻¹)下培养24小时的葡萄糖浓度(0-25mM)的影响。所产生的非糖基化单克隆抗体的比例与细胞暴露于缺乏葡萄糖的培养基中的时间直接相关。在整个24小时内剥夺葡萄糖会导致45%的非糖基化单克隆抗体比例。对细胞内脂质连接寡糖(LLO)稳态水平的分析表明,在葡萄糖限制条件下,全长LLO(Glc3Man9GlcNac2)的量减少,同时较小的甘露糖基聚糖(Man2-5GlcNAc2)增加。通过半乳糖基化和唾液酸化指数(GI和SI)对聚糖微异质性进行定量,结果表明其与细胞特异性葡萄糖摄取直接相关。在用尿苷、锰和半乳糖混合物补充培养基后,GI增加到0.83。这显著高于在类似条件下产生的完全人源化抗体(DP12)或文献中报道的类似抗体。嵌合抗体(EG2)的高GI可能归因于其低分子量和不寻常的结构。这些发现对于在单克隆抗体生产的补料分批培养中可能出现的低底物情况具有重要意义。

相似文献

1
The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and the N-glycosylation profile of a monoclonal antibody.葡萄糖对CHO细胞的可利用性会影响单克隆抗体的细胞内脂质连接寡糖分布、位点占据情况以及N-糖基化谱。
J Biotechnol. 2014 Jan 20;170:17-27. doi: 10.1016/j.jbiotec.2013.11.007. Epub 2013 Nov 25.
2
Low glucose depletes glycan precursors, reduces site occupancy and galactosylation of a monoclonal antibody in CHO cell culture.低糖会消耗聚糖前体,降低中国仓鼠卵巢细胞培养中单克隆抗体的位点占有率和半乳糖基化水平。
Biotechnol J. 2015 Jul;10(7):1051-66. doi: 10.1002/biot.201400662. Epub 2015 Jun 24.
3
CHO cell line specific prediction and control of recombinant monoclonal antibody N-glycosylation.CHO 细胞系特异性预测和重组单克隆抗体 N-糖基化的控制。
Biotechnol Bioeng. 2013 Nov;110(11):2970-83. doi: 10.1002/bit.24959. Epub 2013 Jun 6.
4
Effects of nutrient levels and average culture pH on the glycosylation pattern of camelid-humanized monoclonal antibody.营养水平和平均培养pH值对骆驼科动物人源化单克隆抗体糖基化模式的影响。
J Biotechnol. 2014 Sep 30;186:98-109. doi: 10.1016/j.jbiotec.2014.05.024. Epub 2014 Jul 8.
5
Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.分批补料CHO细胞培养中的氨基酸和葡萄糖代谢会影响抗体的产生和糖基化。
Biotechnol Bioeng. 2015 Mar;112(3):521-35. doi: 10.1002/bit.25450. Epub 2014 Oct 10.
6
Strategic feeding of NS0 and CHO cell cultures to control glycan profiles and immunogenic epitopes of monoclonal antibodies.通过 NS0 和 CHO 细胞培养的策略性喂养来控制单克隆抗体的聚糖结构和免疫原性表位。
J Biotechnol. 2021 Jun 10;333:49-62. doi: 10.1016/j.jbiotec.2021.04.005. Epub 2021 Apr 24.
7
Manganese increases high mannose glycoform on monoclonal antibody expressed in CHO when glucose is absent or limiting: Implications for use of alternate sugars.当葡萄糖缺乏或受限的时候,锰会增加在CHO中表达的单克隆抗体上的高甘露糖糖型:对替代糖使用的启示。
Biotechnol Prog. 2015 Mar-Apr;31(2):460-7. doi: 10.1002/btpr.2029. Epub 2014 Dec 29.
8
Tuning a MAb glycan profile in cell culture: Supplementing N-acetylglucosamine to favour G0 glycans without compromising productivity and cell growth.在细胞培养中调整单克隆抗体聚糖谱:补充N-乙酰葡糖胺以促进G0聚糖生成,同时不影响生产力和细胞生长。
J Biotechnol. 2015 Nov 20;214:105-12. doi: 10.1016/j.jbiotec.2015.09.014. Epub 2015 Sep 18.
9
A multi-pronged investigation into the effect of glucose starvation and culture duration on fed-batch CHO cell culture.一项关于葡萄糖饥饿和培养持续时间对分批补料CHO细胞培养影响的多方面研究。
Biotechnol Bioeng. 2015 Oct;112(10):2172-84. doi: 10.1002/bit.25620. Epub 2015 Aug 13.
10
Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose.通过投喂尿苷、氯化锰和半乳糖来调节抗体半乳糖基化。
Biotechnol Bioeng. 2011 Jul;108(7):1591-602. doi: 10.1002/bit.23075. Epub 2011 Feb 18.

引用本文的文献

1
N-Glycosylation modulators for targeted manipulation of glycosylation for monoclonal antibodies.用于靶向操纵单克隆抗体糖基化的N-糖基化调节剂
Appl Microbiol Biotechnol. 2025 Jan 22;109(1):16. doi: 10.1007/s00253-025-13405-5.
2
Combinatory glycoengineering of monoclonal antibodies and its application in cancer therapy: a narrative review.单克隆抗体的组合糖基工程及其在癌症治疗中的应用:一项叙述性综述
Transl Cancer Res. 2024 Feb 29;13(2):1150-1165. doi: 10.21037/tcr-23-1371. Epub 2024 Feb 21.
3
Innovative Metrics for Reporting and Comparing the Glycan Structural Profile in Biotherapeutics.
创新的生物治疗药物聚糖结构谱报告和比较指标。
Molecules. 2023 Apr 7;28(8):3304. doi: 10.3390/molecules28083304.
4
Large Area Microfluidic Bioreactor for Production of Recombinant Protein.大面积微流控生物反应器用于生产重组蛋白。
Biosensors (Basel). 2022 Jul 14;12(7):526. doi: 10.3390/bios12070526.
5
Post-Translational Modification of Cav1.2 and its Role in Neurodegenerative Diseases.Cav1.2的翻译后修饰及其在神经退行性疾病中的作用
Front Pharmacol. 2022 Jan 17;12:775087. doi: 10.3389/fphar.2021.775087. eCollection 2021.
6
Immunoglobulin G Glycosylation in Diseases.免疫球蛋白 G 糖基化在疾病中的作用。
Exp Suppl. 2021;112:395-431. doi: 10.1007/978-3-030-76912-3_13.
7
Cell Free Remodeling of Glycosylation of Antibodies.抗体糖基化的无细胞重塑。
Methods Mol Biol. 2022;2370:117-146. doi: 10.1007/978-1-0716-1685-7_6.
8
A Roadmap for the Molecular Farming of Viral Glycoprotein Vaccines: Engineering Glycosylation and Glycosylation-Directed Folding.病毒糖蛋白疫苗分子农场路线图:工程化糖基化和糖基化导向折叠
Front Plant Sci. 2020 Dec 3;11:609207. doi: 10.3389/fpls.2020.609207. eCollection 2020.
9
Comparison of Three Glycoproteomic Methods for the Analysis of the Secretome of CHO Cells Treated with 1,3,4--BuManNAc.三种糖蛋白质组学方法用于分析经1,3,4-丁酰基甘露糖胺处理的CHO细胞分泌蛋白质组的比较
Bioengineering (Basel). 2020 Nov 10;7(4):144. doi: 10.3390/bioengineering7040144.
10
Ab locks for improving the selectivity and safety of antibody drugs.抗体药物的选择性和安全性改良的 AB locks。
J Biomed Sci. 2020 Jun 25;27(1):76. doi: 10.1186/s12929-020-00652-z.